These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30717414)

  • 1. Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice.
    Méndez-Lara KA; Farré N; Santos D; Rivas-Urbina A; Metso J; Sánchez-Quesada JL; Llorente-Cortes V; Errico TL; Lerma E; Jauhiainen M; Martín-Campos JM; Alonso N; Escolà-Gil JC; Blanco-Vaca F; Julve J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice.
    Tohyama J; Billheimer JT; Fuki IV; Rothblat GH; Rader DJ; Millar JS
    Atherosclerosis; 2009 Jun; 204(2):418-23. PubMed ID: 18990393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool.
    Azrolan N; Odaka H; Breslow JL; Fisher EA
    J Biol Chem; 1995 Aug; 270(34):19833-8. PubMed ID: 7649994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LXR-dependent regulation of macrophage-specific reverse cholesterol transport is impaired in a model of genetic diabesity.
    Errico TL; Méndez-Lara KA; Santos D; Cabrerizo N; Baila-Rueda L; Metso J; Cenarro A; Pardina E; Lecube A; Jauhiainen M; Peinado-Onsurbe J; Escolà-Gil JC; Blanco-Vaca F; Julve J
    Transl Res; 2017 Aug; 186():19-35.e5. PubMed ID: 28583767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.
    Rotllan N; Llaverías G; Julve J; Jauhiainen M; Calpe-Berdiel L; Hernández C; Simó R; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2011 Feb; 1811(2):104-10. PubMed ID: 21126601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
    Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
    Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice.
    Zanotti I; Maugeais C; Pedrelli M; Gomaraschi M; Salgam P; Calabresi L; Bernini F; Kempen H
    Br J Pharmacol; 2011 Nov; 164(6):1642-51. PubMed ID: 21449977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.
    Vaessen SF; Veldman RJ; Comijn EM; Snapper J; Sierts JA; van den Oever K; Beattie SG; Twisk J; Kuivenhoven JA
    J Gene Med; 2009 Aug; 11(8):697-707. PubMed ID: 19431216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models.
    Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC
    Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration.
    Cimmino G; Giannarelli C; Chen W; Alique M; Santos-Gallego CG; Fuster V; Hajjar RJ; Walsh CE; Badimon JJ
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):325-33. PubMed ID: 21164355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer.
    Cimmino G; Chen W; Speidl WS; Giannarelli C; Ibanez B; Fuster V; Hajjar R; Walsh CE; Badimon JJ
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):405-11. PubMed ID: 19701094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.
    Escolà-Gil JC; Chen X; Julve J; Quesada H; Santos D; Metso J; Tous M; Jauhiainen M; Blanco-Vaca F
    Biochim Biophys Acta; 2013 Apr; 1831(4):691-7. PubMed ID: 23328279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia.
    McManus DC; Scott BR; Franklin V; Sparks DL; Marcel YL
    J Biol Chem; 2001 Jun; 276(24):21292-302. PubMed ID: 11292828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.
    Zhang Y; Zanotti I; Reilly MP; Glick JM; Rothblat GH; Rader DJ
    Circulation; 2003 Aug; 108(6):661-3. PubMed ID: 12900335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways.
    Kiss RS; McManus DC; Franklin V; Tan WL; McKenzie A; Chimini G; Marcel YL
    J Biol Chem; 2003 Mar; 278(12):10119-27. PubMed ID: 12547832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo.
    Rotllan N; Ribas V; Calpe-Berdiel L; Martín-Campos JM; Blanco-Vaca F; Escolà-Gil JC
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):e128-32. PubMed ID: 15994442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice.
    Alexander ET; Vedhachalam C; Sankaranarayanan S; de la Llera-Moya M; Rothblat GH; Rader DJ; Phillips MC
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):320-7. PubMed ID: 21071688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.